Decidual vasculopathy in preeclampsia 3: Prediction and early detectio
Withdrawn
- Conditions
- HELLP syndromepreeclampsia10026908
- Registration Number
- NL-OMON35148
- Lead Sponsor
- niversitair Medisch Centrum Sint Radboud
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 70
Inclusion Criteria
Adult pregnant women at 11-13 weeks gestational age
Exclusion Criteria
Multiple pregnancies, cases with intra-uterine infections, cases with chromosomal abnormalities of the fetus (determined by karyotype, diagnostics will not be performed as part of this study)
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The aim of this study is storage of material and ultrasonic data. Subsequently,<br /><br>a larger study will be designed aimed to develope a tool for the prediction of<br /><br>preeclampsia and decidual vasculopathy. In this future study, the parameters<br /><br>will be levels of biomarkers and measurements of uterine artery flow.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Not applicable.</p><br>